Diego Bagnasco, MD, PhD
Credit: Research Gate
Inhaled triple therapy (ITT), despite being well known to decrease exacerbation rate and improving lung function for patients with asthma, was still not widely used by clinicians due to uncertainty in implementing it into patients’ treatment regimens.1
“Despite [previous] evidence2… ITT is not used enough in patients with asthma, likely due to concerns about using different devices or doubts about therapeutic adherence. Furthermore several treatable traits of asthma, such as, propensity to exacerbations, airflow limitation, neuronal plasticity, small airway dysfunction, mucus hypersecretion, and neutrophilic airway inflammation, can be addressed by inhaled triple therapy,” lead investigator Diego Bagnasco, MD, PhD, Assistant Professor, Department of Internal Medicine…